Medical News

RSS

AngioDynamics introduces redesigned Centros self-centering chronic hemodialysis access catheter

AngioDynamics announced today it has achieved the national launch of the newly redesigned Centros self-centering, chronic hemodialysis access catheter.

10 May 2010

American Oriental Bioengineering first-quarter revenue increases 16.7% to $53.7 million

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the first quarter ended March 31, 2010.

10 May 2010

Repros Therapeutics net loss decreases to $1.1M for first-quarter 2010

Repros Therapeutics today announced financial results for the first quarter ended March 31, 2010.

10 May 2010

UC San Diego researchers discover potential new treatment for familial adenomatous polyposis

A team of University of California, San Diego School of Medicine researchers has discovered that common intestinal bacteria appear to promote tumor growths in genetically susceptible mice, but that tumorigenesis can be suppressed if the mice are exposed to an inhibiting protein enzyme.

10 May 2010

Negative impact of depression on glycemic control in type 2 diabetes patients

In this German prospective representative study of patients with type 2 diabetes, baseline depression predicted problems with medication adherence, problems with health-related behaviors, and unsatisfactory glycemic control at follow-up.

10 May 2010

Drug study results, interpretation favour wishes of sponsor pharmaceutical companies

Drug studies financed by pharmaceutical companies frequently show positive results in favour of the sponsor. In the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107(16): 279-85), a research group headed by the Chairman of the Drug Commission of the German Medical Association, Prof. Wolf-Dieter Ludwig, describes the influence of sponsoring on the results, protocol and quality of drugs studies.

10 May 2010

Forest, Nycomed to present data from six roflumilast posters at ATS International Conference

Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.

10 May 2010

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells (ADRCs) for the treatment of no-option chronic heart disease patients showed the following: the procedure was safe and feasible; it demonstrated a statistically significant improvement in maximum oxygen consumption and patients' aerobic capacity measured as metabolic equivalents

10 May 2010

More genetic sites associated with increase in breast cancer risk discovered

Scientists have found five new regions of the genome that increase a woman's risk of developing breast cancer by between six and 16 per cent, according to a study in Nature Genetics today (Sunday)1.

10 May 2010

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with Aunt Martha's Youth Service Center to deploy NextGen® EHR, NextGen® Practice Management and electronic dental records from Quality Systems.

10 May 2010

CE 3D US creates spatial view for hemodynamic and morphologic evaluation of focal liver tumors

Recently, contrast-enhanced (CE) ultrasound (US) appeared as an important modality to show the vascularity in the areas of interest, and has been used widely in clinical diagnosis of liver lesions. Three dimensional ultrasonography (3D US) allows three orthogonal planes to spatially demonstrate the features of subjects, which has been frequently used in fetal US.

10 May 2010

Majority of Americans concerned about skin cancer but still like tans

When it comes to tanning, dermatologists have long suspected that most people need an attitude adjustment. Now, results of a new survey by the American Academy of Dermatology (Academy) confirmed that the majority of people still idolize the bronzed look of a tan despite wanting to protect themselves from skin cancer.

10 May 2010

UT Southwestern offers advanced lung-cancer patients free screenings of tumors for genetic mutations

UT Southwestern Medical Center is the only site in North Texas participating in a national study that offers advanced lung-cancer patients free screenings of their tumors for genetic mutations, some of which might be targets for treatment with existing or experimental therapies.

10 May 2010

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS) are launching a five-year, $7.5 million natural history study of Duchenne muscular dystrophy (Duchenne), a degenerative genetically-linked neuromuscular disease. The study aims to validate non-invasive approaches to monitor the progression and treatment of Duchenne, and holds potential to facilitate the development of promising new therapies for people with the disease.

10 May 2010

UT Southwestern researchers uncover core function of gene involved in Fragile X syndrome

Researchers at UT Southwestern Medical Center have discovered how the genetic mutation that causes Fragile X syndrome, the most common form of inherited mental retardation, interferes with the "pruning" of nerve connections in the brain. Their findings appear in the April 29 issue of Neuron.

10 May 2010

NIH awards UF scientists $7.5M for study of MRI technology in evaluating children with DMD

Duchenne muscular dystrophy research at the University of Florida got a major boost with the award of $7.5 million in National Institutes of Health funding to study the use of magnetic resonance imaging in determining the natural progression of the disease.

10 May 2010

Groups vie for a piece of health law's $15 billion prevention fund

Kaiser Health News staff writer Julie Appleby reports: "If you had $15 billion to spend on preventing disease in the U.S., where do you think it would do the most good? Fighting obesity? Smoking? Maybe encouraging exercise?

10 May 2010

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced that Takeda has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for VELCADE® (bortezomib) for Injection, a treatment for patients with multiple myeloma.

10 May 2010

ASR increases production of new 5-in-1 non contact thermometers

American Scientific Resources, Inc. announced today that the Company has increased production of its new line of affordable, revolutionary 5-in-1 non contact thermometers to allow for various distribution channels to take full advantage of ASR's production capabilities.

10 May 2010

Allied Healthcare Products reduces cost of sales for third-quarter 2010

Budget constraints for hospitals and municipalities continued to depress sales for Allied Healthcare Products, Inc. but the company managed to improve its third quarter results over last year's performance by reducing overhead and operating costs.

10 May 2010

Medical News

AngioDynamics introduces redesigned Centros self-centering chronic hemodialysis access catheter

American Oriental Bioengineering first-quarter revenue increases 16.7% to $53.7 million

Repros Therapeutics net loss decreases to $1.1M for first-quarter 2010

UC San Diego researchers discover potential new treatment for familial adenomatous polyposis

Negative impact of depression on glycemic control in type 2 diabetes patients

Drug study results, interpretation favour wishes of sponsor pharmaceutical companies

Forest, Nycomed to present data from six roflumilast posters at ATS International Conference

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

More genetic sites associated with increase in breast cancer risk discovered

Integrated NextGen platform to be implemented at Aunt Martha's Youth Service Center

CE 3D US creates spatial view for hemodynamic and morphologic evaluation of focal liver tumors

Majority of Americans concerned about skin cancer but still like tans

UT Southwestern offers advanced lung-cancer patients free screenings of tumors for genetic mutations

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

UT Southwestern researchers uncover core function of gene involved in Fragile X syndrome

NIH awards UF scientists $7.5M for study of MRI technology in evaluating children with DMD

Groups vie for a piece of health law's $15 billion prevention fund

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

ASR increases production of new 5-in-1 non contact thermometers

Allied Healthcare Products reduces cost of sales for third-quarter 2010

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News